Connect your AI

Xtant Medical Holdings XTNT Restricted Cash

Restricted Cash at other companies

Orthofix Medical Inc.OFIX

$592K-76.3%

OrthoPediatricsKIDS

$2.05M+3.1%

Other financials

Income statement

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation

Market cap$59.05M-32.5%

Enterprise value$61.89M-41.5%

P/E32.3×—

P/S0.5×-0.2×

Profitability

Gross margin62.3%+4.2pp

Operating margin4.8%+2.8pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Xtant Medical Holdings's restricted cash?: Xtant Medical Holdings (XTNT) reported restricted cash of $20K in Q1 2026.
How has Xtant Medical Holdings's restricted cash changed year-over-year?: Xtant Medical Holdings's restricted cash decreased by 95.0% year-over-year, from $403K to $20K.
What is the long-term trend for Xtant Medical Holdings's restricted cash?: Over 4 years (2021 to 2025), Xtant Medical Holdings's restricted cash has grown at a 17.6% compound annual growth rate (CAGR), from $144K to $275K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.